PRASAD SUYASH 4
4 · Audentes Therapeutics, Inc. · Filed Jun 7, 2019
Insider Transaction Report
Form 4
PRASAD SUYASH
Senior VP & Chief Med Officer
Transactions
- Tax Payment
Common Stock
2019-06-05$37.31/sh−757$28,244→ 17,479 total
Footnotes (1)
- [F1]Shares relinquished by the Reporting Person and cancelled by the Issuer in exchange for the Issuer's agreement to pay federal and state tax withholding obligations of the Reporting Person resulting from the vesting of restricted stock units. The Reporting Person did not sell or otherwise dispose of the shares for any reason other than to cover required taxes.